trending Market Intelligence /marketintelligence/en/news-insights/trending/kddtjnq_b-2kpobvg3mrlg2 content esgSubNav
In This List

Thermo Fisher says Patheon unit's former CEO to join board

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Thermo Fisher says Patheon unit's former CEO to join board

Thermo Fisher Scientific Inc. said its board elected James Mullen to serve as a director, effective Nov. 8.

Mullen was CEO of Patheon NV until it was acquired by Thermo Fisher. He also previously served as CEO and president of Biogen Inc.

Waltham, Mass.-based Thermo Fisher is a provider of analytical instruments and equipment. The company completed the acquisition of Patheon in August 2017.